Paper36903296
Resveratrol, a New Allosteric Effector of Hemoglobin, Enhances Oxygen Supply Efficiency and Improves Adaption to Acute Severe Hypoxia.
Chu Z and 9 others. Molecules, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Resveratrol, a New Allosteric Effector of Hemoglobin, Enhances Oxygen Supply Efficiency and Improves Adaption to Acute Severe Hypoxia. Papers, record 36903296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36903296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Resveratrol, a New Allosteric Effector of Hemoglobin, Enhances Oxygen Supply Efficiency and Improves Adaption to Acute Severe Hypoxia.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemoglobins | Major topic |
| Hypoxia | Major topic |
| Animals | |
| Mice | |
| Rats | |
| Resveratrol | |
| Molecular Docking Simulation | |
| Oxygen |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35173841 | GBT1118, a voxelotor analog, protects red blood cells from damage during severe hypoxia. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/35173841 | PubMed |
| 2 | 9514179 | Right-shifting the oxyhemoglobin dissociation curve with RSR13: effects on high-energy phosphates and myocardial recovery after low-flow ischemia. | J Cardiovasc Pharmacol | 1998 | https://conductscience.org/library/papers/9514179 | PubMed |
| 3 | 36141103 | A New Model of Hemoglobin Oxygenation. | Entropy (Basel) | 2022 | https://conductscience.org/library/papers/36141103 | PubMed |
| 4 | 31037292 | Zfp217 mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to promote adipogenic differentiation. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/31037292 | PubMed |
| 5 | 29634905 | A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells. | Mol Pharm | 2018 | https://conductscience.org/library/papers/29634905 | PubMed |
| 6 | 30026237 | Allosteric mechanisms underlying the adaptive increase in hemoglobin-oxygen affinity of the bar-headed goose. | J Exp Biol | 2018 | https://conductscience.org/library/papers/30026237 | PubMed |
| 7 | 32468662 | Quantitative Proteomics Reveals the Effects of Resveratrol on High-Altitude Polycythemia Treatment. | Proteomics | 2020 | https://conductscience.org/library/papers/32468662 | PubMed |
| 8 | 34325302 | Salidroside attenuates acute lung injury via inhibition of inflammatory cytokine production. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/34325302 | PubMed |
| 9 | 31396101 | Antisickling Drugs Targeting βCys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin. | Front Physiol | 2019 | https://conductscience.org/library/papers/31396101 | PubMed |
| 10 | 10364140 | High life: A history of high altitude physiology and medicine | BMJ | 1999 | https://conductscience.org/library/papers/10364140 | PubMed |
| 11 | 34225495 | Clinically Relevant Mutations of Mycobacterial GatCAB Inform Regulation of Translational Fidelity. | mBio | 2021 | https://conductscience.org/library/papers/34225495 | PubMed |
| 12 | 8642597 | Crystal structure of T state haemoglobin with oxygen bound at all four haems. | J Mol Biol | 1996 | https://conductscience.org/library/papers/8642597 | PubMed |
| 13 | 15832402 | Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. | Mol Nutr Food Res | 2005 | https://conductscience.org/library/papers/15832402 | PubMed |
| 14 | 34052324 | Resveratrol for cancer therapy: Challenges and future perspectives. | Cancer Lett | 2021 | https://conductscience.org/library/papers/34052324 | PubMed |
| 15 | 34913467 | Genetic variation in haemoglobin is associated with evolved changes in breathing in high-altitude deer mice. | J Exp Biol | 2022 | https://conductscience.org/library/papers/34913467 | PubMed |
| 16 | 24446264 | Detection of efaproxiral (RSR13) and its metabolites in equine by liquid chromatography tandem mass spectrometry. | J Mass Spectrom | 2014 | https://conductscience.org/library/papers/24446264 | PubMed |
| 17 | 16849845 | Influence of allosteric effectors and temperature on oxygen binding properties and the Bohr effect of bovine hemoglobin. | Zoolog Sci | 2006 | https://conductscience.org/library/papers/16849845 | PubMed |
| 18 | 29660913 | GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions. | Clin Hemorheol Microcirc | 2018 | https://conductscience.org/library/papers/29660913 | PubMed |
| 19 | 23798307 | Oxygen transport by hemoglobin. | Compr Physiol | 2012 | https://conductscience.org/library/papers/23798307 | PubMed |
| 20 | 34155211 | Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors. | Nat Commun | 2021 | https://conductscience.org/library/papers/34155211 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41890969 | Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression. | iScience | 2026 | https://conductscience.org/library/papers/41890969 | PubMed |
| 41683691 | Hemocompatibility Evaluation of PEGylated Bovine Hemoglobin. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683691 | PubMed |
| 41683626 | Spermine: A Hemoglobin Modifier That Reduces Autoxidation and Regulates Oxygen Delivery. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683626 | PubMed |
| 40697547 | Curcumin supplementation accelerates high-altitude acclimatization, prevents polycythemia and modulates gut microbiota in male Han population: a randomized controlled trial. | Front Nutr | 2025 | https://conductscience.org/library/papers/40697547 | PubMed |
| 40488064 | Lysine Lactylation of Hemoglobin Promotes Oxygen Release in Red Blood Cells. | ACS Omega | 2025 | https://conductscience.org/library/papers/40488064 | PubMed |
| 38970521 | Effect of Hb conformational changes on oxygen transport physiology. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/38970521 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| HBB | 3043 | PubTator's text mining | https://conductscience.org/library/genes/3043 | NCBI Gene |
| KRT90P | 85340 | PubTator's text mining | https://conductscience.org/library/genes/85340 | NCBI Gene |
| TLX1NB | 100038246 | PubTator's text mining | https://conductscience.org/library/genes/100038246 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36903296
GET https://conductscience.org/api/papers/v1/36903296/references?page=2